Robert Ćhilton

5.5k total citations · 1 hit paper
122 papers, 2.8k citations indexed

About

Robert Ćhilton is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Robert Ćhilton has authored 122 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Endocrinology, Diabetes and Metabolism, 54 papers in Cardiology and Cardiovascular Medicine and 40 papers in Surgery. Recurrent topics in Robert Ćhilton's work include Diabetes Treatment and Management (51 papers), Metabolism, Diabetes, and Cancer (23 papers) and Cardiovascular Function and Risk Factors (22 papers). Robert Ćhilton is often cited by papers focused on Diabetes Treatment and Management (51 papers), Metabolism, Diabetes, and Cancer (23 papers) and Cardiovascular Function and Risk Factors (22 papers). Robert Ćhilton collaborates with scholars based in United States, Germany and Italy. Robert Ćhilton's co-authors include Odd Erik Johansen, Stefano Del Prato, Ralph A. DeFronzo, Hans J. Woerle, Uli C. Broedl, Muhammad Abdul‐Ghani, I. Tikkanen, Christopher P. Cannon, S. Crowe and Rene Oliveros and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Robert Ćhilton

109 papers receiving 2.7k citations

Hit Papers

Effects of empagliflozin on blood pressure and markers of... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
    2015 372 citations Robert Ćhilton, Odd Erik Johansen et al. Diabetes Obesity and Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Ćhilton United States 30 1.6k 882 756 748 361 122 2.8k
Samy Hadjadj France 31 1.4k 0.9× 597 0.7× 668 0.9× 638 0.9× 212 0.6× 159 2.9k
Marcel H.A. Muskiet Netherlands 28 2.5k 1.6× 870 1.0× 1.1k 1.5× 456 0.6× 442 1.2× 66 3.5k
Nicolai Balle Larsen Denmark 17 2.2k 1.4× 1.3k 1.5× 617 0.8× 975 1.3× 258 0.7× 32 4.7k
Hideaki Jinnouchi Japan 26 1.1k 0.7× 768 0.9× 550 0.7× 499 0.7× 127 0.4× 81 2.3k
Kazunori Utsunomiya Japan 32 1.6k 1.1× 1.3k 1.4× 807 1.1× 560 0.7× 323 0.9× 152 4.0k
Ulrich Julius Germany 28 1.5k 1.0× 548 0.6× 1.5k 1.9× 735 1.0× 185 0.5× 173 3.6k
Sang Youb Han South Korea 33 718 0.5× 982 1.1× 541 0.7× 545 0.7× 264 0.7× 115 3.3k
Teresa Salvatore Italy 37 1.4k 0.9× 946 1.1× 668 0.9× 847 1.1× 251 0.7× 91 3.5k
Shinji Koba Japan 31 758 0.5× 490 0.6× 1.2k 1.5× 786 1.1× 273 0.8× 108 2.6k
Harald Sourij Austria 33 1.6k 1.0× 1.1k 1.2× 784 1.0× 752 1.0× 127 0.4× 192 3.5k

Countries citing papers authored by Robert Ćhilton

Since Specialization
Citations

This map shows the geographic impact of Robert Ćhilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Ćhilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Ćhilton more than expected).

Fields of papers citing papers by Robert Ćhilton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Ćhilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Ćhilton. The network helps show where Robert Ćhilton may publish in the future.

Co-authorship network of co-authors of Robert Ćhilton

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Ćhilton. A scholar is included among the top collaborators of Robert Ćhilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Ćhilton. Robert Ćhilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ćhilton, Robert, et al.. (2025). Ketamine in insulin resistance: Pharmacokinetics, cardiovascular implications and cellular effects on cardiomyocytes. Diabetes Obesity and Metabolism. 27(5). 2339–2341.
3.
Howes, Simon R., et al.. (2025). Anesthesia and EMI: Ensuring Safe CIED Management During Surgical Procedures. Journal of Cardiothoracic and Vascular Anesthesia. 39(6). 1534–1537.
4.
Favero, Vittoria, Davide Paolo Bernasconi, Alessandro Maloberti, et al.. (2025). Cardiometabolic Risk Parameters in “Nonfunctioning” Adrenal Incidentalomas: A Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 111(2). e619–e629. 1 indexed citations
5.
6.
7.
Ćhilton, Robert, et al.. (2022). Coronary Artery Perforation: A Rare Serious Complication of Pericardiocentesis. Journal of the Society for Cardiovascular Angiography & Interventions. 1(5). 100409–100409.
8.
Raal, Frederick J., Robert Ćhilton, Naresh Ranjith, et al.. (2020). PCSK9 Inhibitors: From Nature’s Lessons to Clinical Utility. Endocrine Metabolic & Immune Disorders - Drug Targets. 20(6). 840–854. 4 indexed citations
9.
Ćhilton, Robert, et al.. (2019). Withdrawal Notice: Management of Right Atrial Thrombus. Where is the Evidence? : A Narrative Review. Current Cardiology Reviews. 15. 2 indexed citations
10.
Schiewe, M.C., Melanie Freeman, J.B. Whitney, et al.. (2018). Comprehensive assessment of cryogenic storage risk and quality management concerns: best practice guidelines for ART labs. Journal of Assisted Reproduction and Genetics. 36(1). 5–14. 28 indexed citations
11.
Tikkanen, Ilkka, Robert Ćhilton, & Odd Erik Johansen. (2016). Potential role of sodium glucose cotransporter 2 inhibitors in the treatment of hypertension. Current Opinion in Nephrology & Hypertension. 25(2). 81–86. 33 indexed citations
12.
Henry, Robert R., Robert Ćhilton, & W. Timothy Garvey. (2013). New options for the treatment of obesity and type 2 diabetes mellitus (narrative review). Journal of Diabetes and its Complications. 27(5). 508–518. 39 indexed citations
13.
Chiquette, Elaine, et al.. (2012). Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers. SHILAP Revista de lepidopterología. 6 indexed citations
14.
Oliveros, Rene, et al.. (2010). A Cardiologist’s View of Hypoglycemia. Current Atherosclerosis Reports. 12(2). 88–95. 4 indexed citations
15.
Schernthaner, G. & Robert Ćhilton. (2010). Cardiovascular risk and thiazolidinediones—what do meta‐analyses really tell us?. Diabetes Obesity and Metabolism. 12(12). 1023–1035. 43 indexed citations
16.
Oliveros, Rene, et al.. (2009). Impaired fasting glucose as a treatment target in diabetes management. Current Cardiology Reports. 11(6). 460–467. 2 indexed citations
17.
Egan, Brent M., Jan Basile, Robert Ćhilton, & Jerome D. Cohen. (2005). Cardioprotection: The Role of β‐Blocker Therapy. Journal of Clinical Hypertension. 7(7). 409–416. 34 indexed citations
18.
Ćhilton, Robert, Edmund Kenneth Kerut, Dimitrios Charalampidis, et al.. (2004). 1006-57 Atherosclerotic plaque can be quantified using multifractal and wavelet decomposition techniques. Journal of the American College of Cardiology. 43(5). A34–A34. 1 indexed citations
19.
Chiquette, Elaine & Robert Ćhilton. (2002). Cardiovascular disease: Much more aggressive in patients with type 2 diabetes. Current Atherosclerosis Reports. 4(2). 134–142. 25 indexed citations
20.
Walling, Ann, et al.. (1991). Incidence and significance of abnormal signal-averaged ECGS as determined serially after myocardial infarction. Journal of the American College of Cardiology. 17(2). A66–A66. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samy Hadjadj Breakdown of academic impact, for papers by Marcel H.A. Muskiet Breakdown of academic impact, for papers by Nicolai Balle Larsen Breakdown of academic impact, for papers by Hideaki Jinnouchi Breakdown of academic impact, for papers by Kazunori Utsunomiya Breakdown of academic impact, for papers by Ulrich Julius Breakdown of academic impact, for papers by Sang Youb Han Breakdown of academic impact, for papers by Teresa Salvatore Breakdown of academic impact, for papers by Shinji Koba Breakdown of academic impact, for papers by Harald Sourij
Rankless by CCL
2026